Denville Partners

Executive Search: Biotech, Pharma, MedTech and related nonprofits. We help drive drug development and build mission driven teams. Rare & common disorders.

[Denville Partners @PartnerInSearch]

This is beg news !!

[Bio Protocol @BioProtocol]

DeSci is on @RobinhoodApp

BIO is now tradable on Robinhood ↓

[Denville Partners @PartnerInSearch]

@RosserJobs Great post. We would argue that’s true for almost any position that’s critical in nature regardless of title.

[CAMP4 Therapeutics @camp4tx]

Excited to kick off our #CAMP4Fireside Series to highlight the people behind CAMP4. Hear from our CEO, Josh Mandel-Brehm, as he shares a glimpse into what’s ahead. Watch the video, and learn more about our mission here: https://t.co/oHsGTjJJRo

[Jason Ford @JasonFord6]

Biotech startups offer a 'resilience dividend.' Even if a venture fails, the experience of building from scratch is resume gold. These unique skills make it a low-risk career move in the long run.

#BiotechCareers #Resilience #DenvillePartners #Leadership

[Muscular Dystrophy News Today @mdnewstoday_]

Columnist Patrick Moeschen invites readers to join the newly relaunched Muscular Dystrophy News Today Forums, where a community is growing. https://t.co/tuJRY3VHKJ

#musculardystrophynews #musculardystrophy #musculardystrophycommunity #livingwithMD

[Dyne Therapeutics @Dyne_tx]

Today we announced our Q1 2026 financial results highlighting progress across our pipeline. See the press release here https://t.co/R5P40f1q2j

[Denville Partners @PartnerInSearch]

Would you hire you ??

Tough conversations in full transparency:

We are extremely fortunate to have the opportunity to work on very senior level high impact positions.

We are hired to ensure that our client hires the best candidate possible.

Since we are so proactive in our approach, we often end up speaking with multiple highly qualified passionate human beings.

Some or are more qualified than others, and some are better fit than others.

If we are doing our work right, we have to make some very challenging decisions about who and who we don’t present

Telling someone that we have decided not to present their credentials can be a challenging conversation. After all, we are only a search firm, right?

There is typically one of two reactions.
I will let you guess what they are.

Some of these folks become clients for life. The others…….

However, I have found that one question often helps us level set in that question is:

If you were the hiring manager for this position, would you hire you?

Be honest, would you?

[Denville Partners @PartnerInSearch]

Excellent insight as always.

[Nature Biotechnology @NatureBiotech]

Bruce Booth on the successes and failures that have shaped the biotech industry — reflecting on past breakthroughs, changes in the funding landscape, and promising drug modalities now in development https://t.co/Ru97JoSsGp
https://t.co/ukIbdSNZ3E

[Denville Partners @PartnerInSearch]

The mission is pure: support women at each and every step in their career.
While biotech does better than most industries as it relates to equality and diversity, any gap is too big.

Please reach out to our team to learn more.

[Jason Ford @JasonFord6]

Denville Partners is deeply honored to support Women in Bio (WIB) as they search for a new #CEO

We look forward to partnering with the board to find a mission driven leader
#WIB #equality #biotech

Inquiries and questions welcome.

[Denville Partners @PartnerInSearch]

@GillianHSapia A #rare mom would be extra special for sure. It has been our honor to get to know some of these extraordinary humans.

[Denville Partners @PartnerInSearch]

The mission is pure: support women at each and every step in their career.
While biotech does better than most industries as it relates to equality and diversity, any gap is too big.

Please reach out to our team to learn more.

[Jason Ford @JasonFord6]

Denville Partners is deeply honored to support Women in Bio (WIB) as they search for a new #CEO

We look forward to partnering with the board to find a mission driven leader
#WIB #equality #biotech

Inquiries and questions welcome.

[ULF @UlfUnited]

Registration is now open for the ULF Scientific Symposium & Family Conference June 25-27 at Hilton Chicago/Oak Brook Hills Resort & Conference Center, Oak Brook, IL 60523. Take advantage of discounted early bird rates by registering by 3/13/26. Register https://t.co/iCsW3okfwV

[Crinetics Pharmaceuticals @Crinetics]

Kicking off our new Scientific Shorts series: a new series designed to break down big ideas in endocrinology. First up: What is the endocrine system? Watch Crinetics Chief Endocrinologist, Alan Krasner, M.D., explain how the endocrine system plays a critical role in everyday health and helps keep the body in balance.

[PepGen @PepGenTx]

Our potentially disease modifying therapy for myotonic dystrophy type 1, PGN-EDODM1, is being evaluated in the phase 2 FREEDOM2-DM1 clinical study. Learn more in the video below.

[Denville Partners @PartnerInSearch]

Biotech leaders are thinking global, not just local. 🌍 In the race for innovation, top talent can be anywhere: and the best are removing borders to build world-class teams. Where you work matters less than what you bring. #Biotech #Talent #Leadership

[Denville Partners @PartnerInSearch]

AI + digital fluency is now core for rare disease leaders: not just using tech, but shaping it: asking better data questions, setting trust, keeping patients at the center. The winning formula: science + systems + empathy. #RareDisease #AI #DigitalHealth #Biotech

[Denville Partners @PartnerInSearch]

Rare disease breakthroughs go far beyond rare: unlocking platforms for oncology, neuro & immunology. Now’s the time for visionary leaders to translate edge-case science into industry-wide impact. #RareDisease #Biotech #Leadership

[Denville Partners @PartnerInSearch]

Rare disease awareness is evolving; think art, music, AR. Clarity and creativity move hearts and build trust faster than any brochure. For leaders: stories and empathy are the new force multipliers. #RareDisease #Biotech #Healthcare

[Denville Partners @PartnerInSearch]

2026 is rare disease biotech’s “prove it” year. Winning leaders go beyond promise: delivering results with focus, urgency, discipline, and execution across teams. Building for approval + access? Let’s connect. #RareDisease #Biotech

[Denville Partners @PartnerInSearch]

Patient advocates aren’t just “stakeholders”: they’re co-leaders in rare disease R&D. When the patient voice shapes studies, teams move faster and with greater trust. Leadership means listening. #RareDisease #ClinicalTrials